Physician profile
Paul B Stringfellow
NPI 1831165133
$4,503.79
in general payments reported to CMS, 2019-2025
36 companies · $645 in 2025
The $645 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $470 · 2021: $652 · 2022: $764 · 2023: $837 · 2024: $713 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $620.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $601.38 | 2021-2025 | Vraylar |
| Amgen INC. | $536.36 | 2020-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $535.58 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $262.96 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Esperion Therapeutics, INC. | $262.06 | 2020-2025 | Nexletol |
| Glaxosmithkline, LLC. | $259.38 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $189.86 | 2021-2024 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $147.04 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $144.24 | 2019-2023 | |
| Pfizer INC. | $100.18 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $95.65 | 2019-2023 | |
| Exact Sciences Corporation | $77.91 | 2024-2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $71.16 | 2020-2021 | |
| Sanofi Pasteur INC. | $68.52 | 2019-2025 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Stringfellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.